A Trial Evaluating the Safety & Efficacy of Intra-Tumoral Ipilimumab in Combination With Intra-venous Nivolumab in Patients With Metastatic Melanoma
Clinical trial NCT02857569 · COMPLETED
Trial details
- NCT number
- NCT02857569
- Sponsor
- Gustave Roussy, Cancer Campus, Grand Paris
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2016-12-05
- Primary completion
- 2021-01-01
- Enrollment
- 90
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.